首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

2126414

腦電圖診斷市場－策略分析與預測（2026-2035）

EEG Diagnostics Market - Strategic Insights and Forecasts (2026-2035)

出版日期: 2026年08月11日 | 出版商:

Knowledge Sourcing Intelligence | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計腦電圖診斷市場將從 2026 年的 29.3 億美元成長到 2035 年的 53.9 億美元，複合年成長率為 7.0%。

腦電圖（EEG）診斷市場正經歷重大變革，其驅動力包括：精準神經病學模式轉移、人工智慧（AI）的融合以及攜帶式腦監測臨床應用的不斷擴展。這一市場演變的特點是，人們日益認知到，對大腦電活動進行非侵入性測量對於診斷癲癇、睡眠障礙、重症監護疾病、創傷性腦損傷和神經退化性疾病至關重要，因為功能異常通常先於結構影像學變化出現。先進的訊號擷取技術、無線技術和人工智慧分析的融合，使得神經系統評估更加快速、準確、便利。神經系統疾病在全球致殘率和醫療保健成本中佔據相當大的比例，而人口老化和中風率的上升正在推動對先進腦電圖平台的需求，促使醫療系統擴展其神經診斷基礎設施。隨著對人工智慧軟體、穿戴式科技和雲端分析技術的龐大投資，腦電圖診斷正逐漸成為現代神經病學和精準醫學的基石。

市場促進因素

神經系統疾病負擔的日益加重是腦電圖（EEG）診斷市場的主要驅動力。在已開發國家和新興醫療體系中，神經系統疾病仍然是導致殘疾和醫療資源消耗的主要原因。醫療機構正在擴大其腦電圖服務能力，因為早期功能評估能夠提高癲癇、中風、腦病變和神經退化性疾病的診斷準確性。隨著患者轉診數量的持續成長，門診神經科科診所和三級醫療機構對診斷的需求也不斷增加。這種成長推動了先進腦電圖（EEG）系統的應用，這些系統可支援快速診斷並改善神經系統疾病的長期管理，從而導致腦電圖診斷的使用量持續成長。此外，持續神經重症監護監測的擴展也推動了即時腦功能評估的應用，進一步加速了市場成長。持續腦電圖監測可以即時評估嚴重患者的腦功能。長期監測能夠檢測到加護病房。隨著高級生命支持（ALS）技術的普及，重症監護醫師需要持續的神經系統監測。為此，設備製造商正在整合自動癲癇發作檢測和遠端監測功能，以提高神經重症監護環境的工作流程效率。人工智慧（AI）透過自動波形分類和工作流程優先排序來提高診斷效率。 AI驅動的腦電圖（EEG）分析支援自動波形分類、癲癇發作檢測、偽跡移除和工作流程優先排序。由於專家短缺導致波形解讀所需時間增加，醫院擴大採用智慧軟體。臨床軟體開發商正在擴展機器學習功能，以提高結果的可重複性，同時減少觀察者之間的差異。隨著攜帶式腦電圖設備的普及，穿戴式記錄技術使得在傳統檢查室室外進行長期監測成為可能。由於間歇性神經系統異常往往在短期檢查中被漏診，醫生擴大建議進行長期監測。

市場限制因素

與實施、維護和軟體整合相關的高昂成本阻礙了小規模醫院和資源有限的醫療保健系統採用這些技術。先進平台所需的大量投資對小規模醫療機構來說也是一大障礙。儘管診斷需求不斷成長，但訓練有素的神經生理學家和腦電圖技師的短缺限制了解讀取能力。專業人員的匱乏限制了腦電圖服務的擴充性。人工智慧驅動的腦電圖軟體的監管檢驗要求延長了產品上市時間並增加了產品開發成本。對基於人工智慧的演算法的嚴格證據要求給開發人員帶來了巨大的時間和成本負擔。不同司法管轄區的複雜法規給尋求將新型診斷解決方案商業化的製造商帶來了合規負擔。

市場定義和範圍
行業概覽
產業變化
主要市場趨勢
實際成果值市場規模分析
市場預測
神經系統疾病負擔與臨床需求評估
流行病學分析
- 癲癇患者人數
- 睡眠障礙患者人數
- 卒中和重症監護監測的目標患者群
- 神經退化性疾病評估的目標族群
對所進行的腦電圖 (EEG) 檢查次數進行分析
已安裝單元數量分析
臨床工作流程與病人歷程分析

第4章市場動態

市場促進因素
市場限制因素
市場機遇
市場挑戰

第5章行業情勢

產業價值鏈分析
定價分析
還款狀態

第6章：創新趨勢

新型腦電圖技術
產品創新分析
人工智慧驅動的腦電圖（EEG）分析與臨床決策支持
數位健康與遠端腦電圖監測的整合
管道分析
臨床試驗分析
技術藍圖

第7章監理情勢

法律規範
核准流程
合規要求

第8章：全球腦電圖診斷市場：展望分析

分析：依產品類型
分析：依模態
分析：按技術平台
分析：透過臨床應用
分析：透過測試方法
分析：按最終用戶

第9章全球腦電圖診斷市場：細分市場分析

依產品類型
- 腦電圖系統
- 腦電圖配件與耗材
- 腦電圖軟體和分析
按模式
- 常規腦電圖（EEG）
- 攜帶式腦電圖（EEG）
- 視訊腦電圖（EEG）監測
- 連續腦電圖監測
依設備類型
- 獨立式腦電圖
- 無線腦電圖
- 穿戴式可攜式腦電圖
臨床應用
- 癲癇診斷和監測
- 睡眠障礙評估
- 加護病房（ICU）監測
- 中風評估
- 創傷性腦損傷評估
- 失智症和神經退化性疾病的評估
- 其他神經系統用途
最終用戶
- 醫院
- 神經科診所
- 診斷中心
- 其他

第10章：全球腦電圖診斷市場：區域分析

北美洲
歐洲
亞太地區
南美洲
中東和非洲

第11章全球腦電圖診斷市場：國別分析

美國
加拿大
德國
英國
法國
義大利
西班牙
日本
中國
印度
韓國
澳洲
巴西
墨西哥
沙烏地阿拉伯

第12章競爭格局

市佔率分析
策略趨勢
企業合併、商業夥伴關係和合作
新產品發布

第13章：公司簡介

Natus Medical Incorporated
Nihon Kohden Corporation
Compumedics Limited
Cadwell Industries, Inc.
Brain Products GmbH
ANT Neuro BV
Neurosoft
Micromed SpA
EB Neuro SpA
Neuroelectrics
g.tec medical engineering GmbH

第14章：全球腦電圖診斷市場：商業預測分析

第15章投資與資金籌措分析

創業投資趨勢
政府資金
研發投資

第16章：未來展望

主要成長機遇
未來產業趨勢

簡介目錄

Product Code: KSI-009125

The EEG Diagnostics Market is expected to grow at a CAGR of 7.0% to reach market size of USD 5.39 billion in 2035 from USD 2.93 billion in 2026.

The EEG diagnostics market is undergoing significant transformation driven by the paradigm shift toward precision neurology, the integration of artificial intelligence, and the expanding clinical applications of continuous and ambulatory brain monitoring. The market's evolution is characterized by the growing recognition that non-invasive measurement of cerebral electrical activity is essential for diagnosing epilepsy, sleep disorders, critical care conditions, traumatic brain injury, and neurodegenerative diseases, as functional abnormalities frequently precede structural imaging changes. The convergence of advanced signal acquisition, wireless technologies, and AI-assisted interpretation is enabling faster, more accurate, and increasingly accessible neurological assessment. Healthcare systems are expanding neurodiagnostic infrastructure as neurological diseases account for a substantial proportion of global disability and healthcare expenditure, with aging populations and increasing stroke incidence reinforcing demand for advanced EEG platforms. The market is witnessing significant investment in AI-enabled software, wearable technologies, and cloud-based analytics, positioning EEG diagnostics as a cornerstone of modern neurology and precision medicine.

Market Drivers

The rising burden of neurological disorders represents the primary driver for the EEG diagnostics market. Neurological disorders remain a major source of disability and healthcare utilization across both developed and emerging healthcare systems. Healthcare providers are expanding EEG capacity because early functional assessment improves diagnostic confidence for epilepsy, stroke, encephalopathy, and neurodegenerative diseases. Diagnostic demand is increasing across outpatient neurology clinics and tertiary hospitals as patient referrals continue rising. This expansion strengthens procurement of advanced EEG systems that support faster diagnosis while improving long-term neurological disease management, resulting in sustained growth in EEG diagnostic utilization. The expansion of continuous neurocritical care monitoring is further accelerating market growth through increased adoption of real-time cerebral function assessment. Continuous EEG monitoring provides real-time assessment of cerebral function in critically ill patients. Intensive care units are increasing adoption because prolonged monitoring detects non-convulsive seizures that routine EEG examinations frequently miss. Critical care physicians require continuous neurological surveillance as advanced life-support interventions become more common. Device manufacturers are responding by integrating automated seizure detection and remote monitoring capabilities that improve workflow efficiency within neurocritical care environments. Artificial intelligence is improving diagnostic efficiency through automated waveform classification and workflow prioritization. AI-assisted EEG analysis supports automated waveform classification, seizure detection, artifact removal, and workflow prioritization. Hospitals are implementing intelligent software because specialist shortages extend interpretation turnaround times. Clinical software developers are expanding machine-learning capabilities that improve reproducibility while reducing observer variability. The increasing adoption of ambulatory EEG is expanding long-duration monitoring outside conventional laboratories through wearable recording technologies. Physicians increasingly recommend prolonged monitoring because intermittent neurological abnormalities often remain undetected during short-duration examinations.

Market Restraints

High acquisition, maintenance, and software integration costs limit adoption among smaller hospitals and resource-constrained healthcare systems. The significant financial investment required for advanced platforms creates barriers for smaller facilities. Shortage of trained neurophysiologists and EEG technologists restricts interpretation capacity despite increasing diagnostic demand. The limited availability of specialized personnel reduces the scalability of EEG services. Regulatory validation requirements for AI-enabled EEG software extend commercialization timelines and increase product development costs. The rigorous evidence requirements for AI-based algorithms create significant time and cost burdens for developers. Regulatory complexities across different jurisdictions create compliance burdens for manufacturers seeking to commercialize new diagnostic solutions.

Technology and Product Insights

The technology landscape is characterized by the growing importance of integrated digital ecosystems combining hardware, software, cloud infrastructure, and clinical decision support. EEG systems represent the largest product category because hospitals require integrated hardware platforms capable of supporting routine diagnostics, continuous monitoring, and advanced neurological investigations. Healthcare providers are replacing legacy equipment with digital systems that improve signal quality, interoperability, and workflow automation. Manufacturers are integrating AI-assisted interpretation, wireless acquisition, and cloud connectivity into next-generation platforms because clinicians increasingly prioritize operational efficiency alongside diagnostic performance. Continuous EEG monitoring experiences strong adoption because intensive care physicians require uninterrupted assessment of cerebral electrical activity during critical neurological events. Demand is increasing across neurocritical care units where prolonged monitoring improves identification of non-convulsive seizures and evolving cerebral dysfunction. The segment analysis reveals that epilepsy diagnosis and monitoring remain the largest clinical application because EEG provides direct assessment of epileptiform activity that guides diagnosis and treatment decisions. Neurologists increasingly utilize prolonged and ambulatory EEG because intermittent seizures frequently escape detection during conventional examinations. Hospitals represent the leading end-user segment, with neurology clinics and diagnostic centers expanding EEG capabilities. The integration of AI is becoming increasingly important because AI-assisted EEG analysis supports automated waveform classification, seizure detection, artifact removal, and workflow prioritization.

Competitive and Strategic Outlook

The competitive landscape features established neurodiagnostics companies alongside specialized software, wearable, and analytics providers. Natus Medical remains strategically distinct because it offers one of the industry's broadest neurodiagnostic portfolios spanning EEG, electromyography, sleep diagnostics, newborn care, and hearing assessment, continuing to strengthen integrated neurodiagnostic workflows that combine advanced acquisition hardware with enterprise software platforms. Nihon Kohden differentiates itself through its broad critical care monitoring expertise, allowing EEG technologies to integrate seamlessly with patient monitoring platforms used throughout hospitals, continuing to expand neurological monitoring solutions that support intensive care, emergency medicine, perioperative monitoring, and specialized neuroscience departments. Compumedics maintains a strong competitive position through specialization in neurodiagnostics and sleep medicine supported by advanced software analytics and cloud-enabled workflow capabilities, continuing to invest in AI applications that improve seizure detection, sleep analysis, and quantitative EEG interpretation. Cadwell Industries focuses on high-quality neurophysiology systems designed for EEG, electromyography, intraoperative monitoring, and evoked potential studies. Brain Products distinguishes itself through leadership in advanced neuroscience research technologies and high-density EEG solutions. Neuroelectrics differentiates itself by combining wearable EEG technology with non-invasive brain stimulation platforms that support both clinical research and emerging neurological therapies. Companies are pursuing product portfolio expansion through innovation in AI-enabled software, wearable EEG technologies, and cloud-based analytics. Recent key developments include Zeto launching NeuroNotis as a hybrid EEG reporting service that combines AI seizure detection with technical review by Registered EEG Technologists. Natus launched autoSCORE as an AI-assisted EEG analysis tool designed to provide expert-level interpretation support at scale. Geographic expansion remains a key strategic priority, with companies targeting rapidly growing Asia Pacific and emerging markets where healthcare infrastructure is expanding.

Short Conclusion

The EEG diagnostics market is positioned for sustained growth driven by the convergence of neurological disease burden, technological innovation, and digital health transformation. The transition from conventional signal acquisition toward intelligent neurodiagnostic ecosystems represents a fundamental shift in neurological care. While challenges related to high costs, workforce shortages, and regulatory validation persist, strategic investments in technology, automation, and partnerships are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with EEG diagnostics evolving into a cornerstone of precision neurology, supporting earlier diagnosis, continuous monitoring, and improved patient outcomes across global healthcare systems.

Key Benefits of this Report

Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2035
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation, and trade analysis
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. Executive Summary

1.1 Market Snapshot
1.2 Key Findings
1.3 Analyst Insights
1.4 Strategic Recommendations

2. Research Methodology

2.1 Research Design
2.2 Data Collection Methodology
2.3 Market Size Estimation
2.4 Forecasting Model
2.5 Assumptions & Limitations

3. Global EEG Diagnostics Market Overview, Size & Forecast

3.1 Market Definition & Scope
3.2 Industry Overview
3.3 Industry Evolution
3.4 Key Market Trends
3.5 Historical Market Size Analysis (2021-2025)
3.6 Market Forecast (2026-2035)
3.7 Neurological Disease Burden and Clinical Need Assessment
3.8 Epidemiology Analysis
- 3.8.1 Epilepsy Patient Population
- 3.8.2 Sleep Disorders Patient Population
- 3.8.3 Stroke and Critical Care Monitoring Population
- 3.8.4 Neurodegenerative Disease Assessment Population
3.9 EEG Testing Volume Analysis
3.10 Installed Base Analysis
3.11 Clinical Workflow and Patient Journey Analysis

4. Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5. Industry Landscape

5.1 Industry Value Chain Analysis
5.2 Pricing Analysis
5.3 Reimbursement Landscape

6. Innovation Landscape

6.1 Emerging EEG Technologies
6.2 Product Innovation Analysis
6.3 AI-Based EEG Interpretation and Clinical Decision Support
6.4 Digital Health and Remote EEG Monitoring Integration
6.5 Pipeline Analysis
6.6 Clinical Trial Analysis
6.7 Technology Roadmap

7. Regulatory Landscape

7.1 Regulatory Framework
7.2 Approval Pathways
7.3 Compliance Requirements

8. Global EEG Diagnostics Market Landscape Analysis

8.1 Analysis by Product Type
8.2 Analysis by Modality
8.3 Analysis by Technology Platform
8.4 Analysis by Clinical Application
8.5 Analysis by Testing Methodology
8.6 Analysis by End User

9. Global EEG Diagnostics Market Segment Analysis (2021-2035)

9.1 By Product Type
- 9.1.1 EEG Systems
- 9.1.2 EEG Accessories & Consumables
- 9.1.3 EEG Software & Analytics
9.2 By Modality
- 9.2.1 Routine EEG
- 9.2.2 Ambulatory EEG
- 9.2.3 Video EEG Monitoring
- 9.2.4 Continuous EEG Monitoring
9.3 By Device Type
- 9.3.1 Standalone EEG
- 9.3.2 Wireless EEG
- 9.3.3 Wearable & Portable EEG
9.4 By Clinical Application
- 9.4.1 Epilepsy Diagnosis & Monitoring
- 9.4.2 Sleep Disorder Evaluation
- 9.4.3 Intensive Care Unit (ICU) Monitoring
- 9.4.4 Stroke Assessment
- 9.4.5 Traumatic Brain Injury Assessment
- 9.4.6 Dementia & Neurodegenerative Disease Assessment
- 9.4.7 Other Neurological Applications
9.5 By End User
- 9.5.1 Hospitals
- 9.5.2 Neurology Clinics
- 9.5.3 Diagnostic Centers
- 9.5.4 Others